MIR4701

Across TCGA pan-cancer cohorts, MIR4701 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MIR4701’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where MIR4701 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR4701 is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

LIHC, BRCA, and CHOL are the cancer types where MIR4701 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR4701 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	All	All	+0.332	<.001	7	view →
BRCA	Female	All	−0.580	<.001	4	view →
CHOL	All	All	+1.588	.002	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

MIR4701–LIHC

Open the LIHC breakdown →